36ACTIVITIES
2ORGS REPRESENTED
18BILLS
Revolving door — covered positions
Federal positions Alexa held before / during the 2-year LDA window. This is the credibility signal — who they were inside the building before they started lobbying it.
Dir. of Operations, Rep. Broun, 2014
Staff Assistant, Rep. Broun, 2014, Intern, Rep. Price, 2014
Organizations represented
2Orgs whose LD-2 filings list Alexa as an active lobbyist, sorted by activity volume.
Bills they file on
18H.R. 165014 mentions
S. 76314 mentions
H.R. 252814 mentions
S. 184713 mentions
H.R. 670312 mentions
H.R. 629411 mentions
H.R. 729111 mentions
S. 312211 mentions
H.R. 6613 mentions
H.R. 22133 mentions
S. 9983 mentions
H.R. 22703 mentions
H.R. 9192 mentions
H.R. 25712 mentions
S. 10962 mentions
+ 3 more bills referenced in their activities
Topics in Filings
61Policy topics Alexa files on across all their LD-2 activities.
Executive Order 14297×22
Delivering Most‑Favored‑Nation Prescription Drug Pricing to American Patients×22
TRUMP AMERICA AI Act×22
Telehealth Expansion Act×16
Association Health Plans Act×14
Health reimbursement arrangements and other account-based group health plans×14
Mental health parity×14
Federal Trade Commissions multilateral pharmaceutical merger taskforce×14
Telehealth, including coverage of telehealth under High-Deductible Health Plans×14
Impact of Pharmacy Benefit Managers Practices×14
Petition to HHS to grant march-in rights for the patents on the drug Xtandi×14
Legislative proposals to tax employer-provided health care coverage×14
Show all 61 topics (+49 more) ▾
Artificial price caps on providing insulin×14
Efforts to reform×14
World Health Organizations×14
Continued U.S. membership to the WHO×14
Promote greater harmonization of standards and investment in digital health×14
Health-related policy×14
Various issues×12
Childhood Diabetes Reduction Act×11
GRAS Oversight×11
Better FDA Act×11
Proposals to reform×11
Federal preemption for policies×11
2027 Medicare Advantage and Part D Advance Notice×11
MIRACLE Medical Technology Act×3
Medical Supply Chain Resiliency Act×3
Empowering Employer Child and Elder Care Solutions Act×3
Balance or surprise billing and related issues×3
Single-payer health care options×3
Health and Human Services international pricing index×3
COBRA subsidies×3
Reasonable Price Clause in reauthorization×3
Draft of the Pandemic and All Hazards Preparedness Act×3
P.L. 109-417×3
Support for private sector involvement in health systems strengthening×3
One Big Beautiful Bill Act×2
Chronic Disease Flexible Coverage Act×2
Self-Insurance Protection Act×2
Preserve Access to Affordable Generics and Biosimilars Act×2
Mental Health Parity and Addiction Equity Act×2
Reg. 77,586-77,751×2
September 23, 2024×2
Affordable Care Act×2
Departments of Labor×1
Centers for Medicare & Medicaid Services×1
Department of Health and Human Services×1
January 31, 2024×1
Drug pricing×1
Combatting anti-microbial resistance×1
Final Rule×1
Ultra Processed Foods×1
Reg. 35,305-35,309×1
July 25, 2025×1
NIH Artificial Intelligence Strategy×1
July 15, 2025 Request for Information×1
Reg. 20,478-20,481×1
July 14, 2025×1
Tax credit expiration×1
Child Care Modernization×1
Tax credits×1
Issue mix
LDA general-issue codes weighted by activity count.
Health Issues14
Food Industry (safety, labeling, etc.)11
Medicare/Medicaid11